ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (38)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marti, S.
Right arrow Articles by Morell, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marti, S.
Right arrow Articles by Morell, F.
Eur Respir J 2002; 20:1511-1518
Copyright ©ERS Journals Ltd 2002


Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment

S. Marti1, G. Sampol1, X. Muñoz1, F. Torres2, A. Roca1, P. Lloberes1, T. Sagalés3, P. Quesada4 and F. Morell1

1 Servei de Pneumologia, 3 Neurofisiologia Clínica and 4 Otorrinolaringologia, Hospital General Vall d'Hebron and 2 Laboratori de Bioestadística i Epidemiologia, Universitat Autònoma de Barcelona, Barcelona, Spain

CORRESPONDENCE: S. Martí, Servei de Pneumologia, Hospital General Vall d'Hebron, Passeig Vall d'Hebron, 119–129, 08035, Barcelona, Spain. Fax: 34 932746083. E-mail: smartib@hg.vhebron.es

Keywords: cardiovascular diseases, mortality, sleep apnoea syndrome, therapeutics

Received: January 4, 2002
Accepted July 12, 2002

This study was financed in part by a grant from Agència d'Avaluació de Tecnologia Mèdica (Servei Català de la Salut).

The aim of this study was to determine mortality in patients with sleep apnoea/hypopnoea syndrome (SAHS) according to the treatments employed and comorbidity.

An historical cohort of patients with SAHS diagnosed at a university hospital between 1982 and 1992 and followed until 1996 was studied. From a total of 475 SAHS patients, 444 (94%), with a mean±sd apnoea/hypopnoea index at diagnosis of 55±27, were located and included in the study. SAHS treatments employed were: surgery (88), weight loss (134), continuous positive airway pressure (124) and 98 patients were not treated.

By the end of follow-up, 49 patients had died. According to Cox regression analysis, mortality in treated patients was lower than in those not treated, but higher in those with a history of severe chronic obstructive pulmonary disease. Mortality in nontreated patients compared with that of the general population, adjusted for age and sex, showed excessive mortality, which decreased in treated patients. Stratification by age showed a greater mortality rate ratio in patients <50 yrs. These findings were maintained when mortality from cardiovascular causes was compared.

In conclusion, a rise in mortality was found in nontreated sleep apnoea/hypopnoea syndrome patients compared with the general population, whereas mortality in those treated for sleep apnoea/hypopnoea syndrome did not differ significantly from that of the general population.




This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
M. H. Sanders, J. M. Montserrat, R. Farre, and R. J. Givelber
Positive Pressure Therapy: A Perspective on Evidence-based Outcomes and Methods of Application
Proceedings of the ATS, February 15, 2008; 5(2): 161 - 172.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. J. Buchner, B. M. Sanner, J. Borgel, and L. C. Rump
Continuous Positive Airway Pressure Treatment of Mild to Moderate Obstructive Sleep Apnea Reduces Cardiovascular Risk
Am. J. Respir. Crit. Care Med., December 15, 2007; 176(12): 1274 - 1280.
[Abstract] [Full Text] [PDF]


Home page
ERRHome page
P. Lavie
Mortality in sleep apnoea syndrome: a review of the evidence
Eur. Respir. Rev., December 1, 2007; 16(106): 203 - 210.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
B. Mokhlesi and A. Tulaimat
Recent Advances in Obesity Hypoventilation Syndrome
Chest, October 1, 2007; 132(4): 1322 - 1336.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. Parati, C. Lombardi, and K. Narkiewicz
Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1671 - R1683.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
C. Hernandez, J. Abreu, P. Abreu, A. Castro, and A. Jimenez
Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP
Eur. Respir. J., September 1, 2007; 30(3): 496 - 500.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. C. Basner
Continuous Positive Airway Pressure for Obstructive Sleep Apnea
N. Engl. J. Med., April 26, 2007; 356(17): 1751 - 1758.
[Full Text] [PDF]


Home page
Eur Respir JHome page
W. T. McNicholas, M. R. Bonsignore, and the Management Committee of EU COST ACTION B26
Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities
Eur. Respir. J., January 1, 2007; 29(1): 156 - 178.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
E. J. Kezirian, E. M. Weaver, B. Yueh, S. F. Khuri, J. Daley, and W. G. Henderson
Risk factors for serious complication after uvulopalatopharyngoplasty.
Arch Otolaryngol Head Neck Surg, October 1, 2006; 132(10): 1091 - 1098.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
K. Minoguchi, T. Yokoe, A. Tanaka, S. Ohta, T. Hirano, G. Yoshino, C. P. O'Donnell, and M. Adachi
Association between lipid peroxidation and inflammation in obstructive sleep apnoea.
Eur. Respir. J., August 1, 2006; 28(2): 378 - 385.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
H. K. Yaggi, J. Concato, W. N. Kernan, J. H. Lichtman, L. M. Brass, and V. Mohsenin
Obstructive Sleep Apnea as a Risk Factor for Stroke and Death.
N. Engl. J. Med., November 10, 2005; 353(19): 2034 - 2041.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. Minoguchi, T. Yokoe, T. Tazaki, H. Minoguchi, A. Tanaka, N. Oda, S. Okada, S. Ohta, H. Naito, and M. Adachi
Increased Carotid Intima-Media Thickness and Serum Inflammatory Markers in Obstructive Sleep Apnea
Am. J. Respir. Crit. Care Med., September 1, 2005; 172(5): 625 - 630.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
F. Campos-Rodriguez, N. Pena-Grinan, N. Reyes-Nunez, I. De la Cruz-Moron, J. Perez-Ronchel, F. De la Vega-Gallardo, and A. Fernandez-Palacin
Mortality in Obstructive Sleep Apnea-Hypopnea Patients Treated With Positive Airway Pressure
Chest, August 1, 2005; 128(2): 624 - 633.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. S. Doherty, J. L. Kiely, V. Swan, and W. T. McNicholas
Long-term Effects of Nasal Continuous Positive Airway Pressure Therapy on Cardiovascular Outcomes in Sleep Apnea Syndrome
Chest, June 1, 2005; 127(6): 2076 - 2084.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. Lavie, L. Lavie, and P. Herer
All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age
Eur. Respir. J., March 1, 2005; 25(3): 514 - 520.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the European Respiratory Society.